Julian Adlard - Concepedia

Author

Julian Adlard

Also Known As

Adlard, Julian, Adrien Julian, Alain Lortholary, Angela Brady, Couch, Fergus J., D G Evans, D. Barton, Debra Frost, EMBRACE Collaborators, Elena Fineberg

121

Publications

13K

Citations

H-Index

Concepts

All Affiliations

University of Cambridge Guy's and St Thomas' NHS Foundation Trust Institute of Cancer Research Chapel Allerton Hospital Royal Marsden NHS Foundation Trust

About

Julian Adlard is an author at University of Cambridge specializing in medicine, cancer genetics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	2.4K
2	Engineering	1	1	37
3	Health Sciences	1	1	166
4	Natural Sciences	1	1	44
5	Nursing	1	1	10

Julian Adlard

Publications

9.3K

Citations

H-Index

Page 1

	Year	Citations
Risks of Breast, Ovarian, and Contralateral Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers Karoline Kuchenbaecker, John L. Hopper, Daniel R. Barnes, JAMA	2017	2.7K
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE Nasim Mavaddat, Susan Peock, Debra Frost, JNCI Journal of the National Cancer Institute	2013	914
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer Catherine M. Phelan, Karoline Kuchenbaecker, Jonathan P. Tyrer, Nature Genetics Different HistotypesEpithelial Ovarian CancerMedicineGynecologyPathology	2017	536
Germline mutations in RAD51D confer susceptibility to ovarian cancer Chey Loveday, Clare Turnbull, Emma Ramsay, Nature Genetics GeneticsGermline MutationsCancer GeneticsMedicineOvarian Cancer	2011	526
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer Timothy R. Rebbeck, Nandita Mitra, Fei Wan, JAMA	2015	484
Cancer Risks Associated With Germline<i>PALB2</i>Pathogenic Variants: An International Study of 524 Families Xin Yang, Goska Leslie, Alicja Doroszuk, Journal of Clinical Oncology	2019	393
Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer Elena Castro, Chee Goh, Daniel Leongamornlert, European Urology UrologyGenitourinary CancerMedicinePathologyMetastatic Relapse	2014	362
Mutational spectrum in a worldwide study of 29,700 families with<i>BRCA1</i>or<i>BRCA2</i>mutations Timothy R. Rebbeck, Tara M. Friebel, Eitan Friedman, Human Mutation Brca1 MutationsGenetic TestingGeneticsGenetic EpidemiologyMolecular Genetics	2018	298
Predictive Biomarkers of Chemotherapy Efficacy in Colorectal Cancer: Results From the UK MRC FOCUS Trial Michael Braun, Susan D. Richman, Philip Quirke, Journal of Clinical Oncology	2008	275
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer Elise Ruark, Katie Snape, Peter Humburg, Nature Breast OncologyCancer PathologyTumor HeterogeneityGeneticsMosaic Ppm1d Mutations	2012	256

Page 1